Different integrin types recognise and bind a range of ligands with various affinities.
LXY30 also binds to several other known α3β1 integrin-expressing glioblastoma, lung, and breast cancer cell lines with various affinities.
Furthermore, LXY30 binds to the surface of a panel of basal-like breast and metastatic NSCLC cell lines with various affinities.
They are located in liver tissue where they influence hepatocyte proliferation and differentiation by directing or interacting with other matrix components (Barbetta et al. 2008), and they also bind with high affinity to various kinds of growth factors (Deakin et al. 2009).
1A and B bind with approximately equal affinity, although the exact affinity could not be obtained as each DNA binds more than one MA.
These analogues bind with extraordinary affinity relative to reactants.
Indeed, dextro enantiomers bind with high affinity σ1 receptor while opposite enantiomers bind opioid receptors.
First, they bind with high affinity and specificity to a wide variety of proteins.
Various activating ligands were identified, which may bind with a distinct affinity to VEGFR family members.
Importantly, ADP binds with low affinity, which is insufficient to interfere with binding or release of these high affinity inhibitors.
